Yüklüyor......
Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage
Ranolazine received Food and Drug Administration (FDA) approval in 2006 for the treatment of chronic angina. Ranolazine has previously been linked to the development of statin-induced myopathy, because it also inhibits CYP3A4, which increases serum statin levels. In the absence of concomitant statin...
Kaydedildi:
| Yayımlandı: | Cureus |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cureus
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6101463/ https://ncbi.nlm.nih.gov/pubmed/30131925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2832 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|